Sunday, September 20, 2026

MP Materials targets $700M+ magnet capacity expansion to 10,000 tonnes by 2028

MP Materials plans to commission its 10X magnet manufacturing facility in 2028, scaling annual production capacity from 1,000 to 10,000 metric tonnes. The expansion represents a tenfold increase in domestic rare earth magnet output as U.S. manufacturers seek alternatives to China-dominated supply chains.

Source Trace Score1 source document1 with a live linkVerifiability: Basic
MP Materials targets $700M+ magnet capacity expansion to 10,000 tonnes by 2028
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

MP Materials is targeting 2028 commissioning for its 10X magnet manufacturing facility, a project designed to increase annual production capacity from 1,000 to 10,000 metric tonnes. The tenfold expansion positions the company to capture growing demand from electric vehicle and renewable energy sectors.

The facility investment addresses critical supply chain vulnerabilities. China controls roughly 90% of global rare earth magnet production, creating concentration risk for U.S. defense contractors and automotive manufacturers. MP Materials operates North America's only integrated rare earth mining and processing site at Mountain Pass, California.

Rare earth magnets generate $2.8 billion in annual U.S. imports, primarily from Chinese suppliers. The 10,000-tonne target would cover approximately 15% of current domestic consumption, assuming stable demand growth through 2028. EV motors require 1-2 kilograms of neodymium-iron-boron magnets per vehicle, translating to potential supply for 5-10 million units annually.

Capital expenditure for the 10X facility has not been publicly disclosed. Comparable magnet manufacturing plants in China cost $200-300 million for 5,000-tonne capacity, suggesting MP Materials' investment likely exceeds $400 million. The company reported $535 million in cash and equivalents as of Q3 2024, indicating probable debt or equity financing needs.

Commissioning timelines carry execution risk. Magnet manufacturing requires precise temperature control and coating processes that typically take 18-24 months to optimize. Any delays push revenue generation into 2029 or beyond, extending payback periods for investors.

The expansion supports U.S. Department of Defense initiatives to secure domestic magnet supplies for guided missiles, jet fighters, and submarines. Pentagon contracts often include premium pricing for guaranteed domestic sourcing, potentially improving margins versus commercial sales.

MP Materials shares trade at 3.2x forward sales, above the 2.1x average for specialty materials manufacturers. Investors are pricing in successful execution of the capacity expansion and sustained rare earth prices above $65 per kilogram.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score1 source document1 with a live linkVerifiability: Basic
  1. [1]News articleYahoo Finance· January 13, 2026
    Will the US’ onshoring strategy remove China’s chokehold on REEs?
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com